CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,353 | -82.2% | 10,101 | -83.0% | 0.00% | – |
| Q2 2023 | $367,463 | -3.8% | 59,364 | -40.2% | 0.00% | – |
| Q1 2023 | $382,000 | +979387.2% | 99,225 | +678.4% | 0.00% | – |
| Q4 2022 | $39 | -99.7% | 12,747 | +275.9% | 0.00% | – |
| Q3 2022 | $14,000 | -98.4% | 3,391 | -98.1% | 0.00% | – |
| Q2 2022 | $869,000 | +1969.0% | 178,414 | +3683.2% | 0.00% | – |
| Q1 2022 | $42,000 | -17.6% | 4,716 | +4.6% | 0.00% | – |
| Q4 2021 | $51,000 | +70.0% | 4,509 | +146.7% | 0.00% | – |
| Q3 2021 | $30,000 | -36.2% | 1,828 | -12.5% | 0.00% | – |
| Q2 2021 | $47,000 | – | 2,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 17,923,892 | $299,329,000 | 65.12% |
| Vida Ventures Advisors, LLC | 3,931,818 | $65,661,000 | 18.81% |
| Samsara BioCapital, LLC | 1,537,533 | $25,677,000 | 4.03% |
| VR Adviser, LLC | 1,127,272 | $18,825,000 | 2.42% |
| Logos Global Management LP | 1,069,545 | $17,861,000 | 1.29% |
| Cormorant Asset Management, LP | 1,727,273 | $28,724,000 | 1.17% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $161,686,000 | 0.95% |
| Affinity Asset Advisors, LLC | 203,183 | $3,393,000 | 0.86% |
| RA Capital Management | 3,577,094 | $59,737,000 | 0.83% |
| Boxer Capital, LLC | 1,334,227 | $22,282,000 | 0.78% |